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Genomic analysis and immune 
response in a murine mastitis 
model of vB_EcoM-UFV13, a 
potential biocontrol agent for use in 
dairy cows
Vinícius da Silva Duarte1, Roberto Sousa Dias1, Andrew M. Kropinski2, Stefano Campanaro3, 
Laura Treu3,4, Carolina Siqueira5, Marcella Silva Vieira5, Isabela da Silva Paes5, Gabriele Rocha 
Santana5, Franciele Martins5, Josicelli Souza Crispim1, André da Silva Xavier6, Camila Geovana 
Ferro7, Pedro M. P. Vidigal8, Cynthia Canêdo da Silva1 & Sérgio Oliveira de Paula5
Bovine mastitis remains the main cause of economic losses for dairy farmers. Mammary pathogenic 
Escherichia coli (MPEC) is related to an acute mastitis and its treatment is still based on the use of 
antibiotics. In the era of antimicrobial resistance (AMR), bacterial viruses (bacteriophages) present as an 
efficient treatment or prophylactic option. However, this makes it essential that its genetic structure, 
stability and interaction with the host immune system be thoroughly characterized. The present study 
analyzed a novel, broad host-range anti-mastitis agent, the T4virus vB_EcoM-UFV13 in genomic terms, 
and its activity against a MPEC strain in an experimental E. coli-induced mastitis mouse model. 4,975 
Single Nucleotide Polymorphisms (SNPs) were assigned between vB_EcoM-UFV13 and E. coli phage T4 
genomes with high impact on coding sequences (CDS) (37.60%) for virion proteins. Phylogenetic trees 
and genome analysis supported a recent infection mix between vB_EcoM-UFV13 and Shigella phage 
Shfl2. After a viral stability evaluation (e.g pH and temperature), intramammary administration (MOI 10) 
resulted in a 10-fold reduction in bacterial load. Furthermore, pro-inflammatory cytokines, such as IL-6 
and TNF-α, were observed after viral treatment. This work brings the whole characterization and immune 
response to vB_EcoM-UFV13, a biocontrol candidate for bovine mastitis.
Bovine mastitis remains the main cause of economic losses for dairy farmers, estimated at $ (US)533 billion 
worldwide, as well as public health concerns, since low quality milk can be considered a vehicle for pathogen 
transmission1–3.
Mastitis treatment is typically based on the use of short and long-acting antibiotics, respectively, during the lac-
tation and dry period4. In terms of the lactation period and specifically regarding clinical mastitis, Escherichia coli, 
Streptococcus uberis, Streptococcus dysgalactiae and Staphylococcus aureus are the main etiological agents involved 
that have been routinely isolated5. Among these pathogens, mammary pathogenic Escherichia coli (MPEC) is 
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responsible for an acute mastitis characterized by inflammation, increased somatic cell count (SCC) and impaired 
milk quality even after the infection has been cured6.
Using E. coli strains obtained from different types of mastitis (e.g per-acute and persistent) and the 
non-pathogenic strain K71, Blum et al. (2017) performed a mammary immune response comparison in experi-
mentally infected cows and noticed differences regarding TNF-α, IL-6 and IL-17 secretion levels for each MPEC.
Within the current scenario of widespread antibiotic-resistant bacteria, bacterial viruses present as an efficient 
therapeutic or prophylactic tool in order to control different pathogens in dairy cows at different lactation stages. 
This is supported by current in vitro and in vivo assays7–13.
Considered a model system in molecular biology, coliphage T4 has been studied since the 1940s and pos-
sesses about 300 genes organized in a 168.9 kb linear dsDNA with an average GC content of 34.5%14. Lytic 
viruses related to T4 have awoken interest for their application in phage therapy due the absence of lysogenic 
modules, a broad-host-range (from Proteobacteria to Cyanobacteria phyla) and, recently, the identification of 
virion-associated peptidoglycan hydrolases (VAPGHs), which are considered potential enzybiotics15–17.
Indeed, T4 was used by Bruttin18 in the first safety test of phage therapy in humans and in immunological 
assays in order to elucidate the interactions between viruses, its host and the immune system. Bocian et al.19 inves-
tigated how purified T4 phage and T4-generated E. coli lysate impact immune cells differentiation, highlighting 
that lysis of Gram-negative bacteria by phages might not trigger excessive monocyte induction.
Currently, several studies have been exploited the use of mouse models in the attempt to evaluate novels 
anti-mastitis drugs mainly against E. coli and S. aureus20–26. The use of animal models is time and cost effective 
approach, along with a previous step for pre-clinical and clinical assays27. However, the absence of intrinsic cow 
factors can be considered a bottleneck when data is analyzed28.
The aims of the present study were to characterize the Escherichia phage UFV13, a T4virus, in genomic, 
protein and physiological terms and evaluate the immune response in an experimental E. coli-induced mastitis 
mouse model with the aim to use it in clinical trials to control mastitis in dairy cows.
Materials and Methods
vB_EcoM-UFV13 isolation and purification. vB_EcoM-UFV13 (UFV13) was obtained from the sewer-
age system of Viçosa, Minas Gerais state, Brazil and was propagated on Escherichia coli 30 following the well-es-
tablished Sambrook & Russell29 protocol. This virus belongs to the bacterial virus collection of the Laboratório de 
Imunovirologia Molecular (LIMV) at Universidade Federal de Viçosa (UFV), Viçosa city, Brazil.
After virus propagation, viral particles were purified by a three-step protocol using ion exchange and desalting 
columns in a chromatography system (ÄKTAprime plus, GE Healthcare Life Sciences, Uppsala, Sweden). Briefly, 
an initial step using HiTrap Desalting prepacked column (GE Healthcare Life Sciences, Uppsala, Sweden) was 
conducted to remove any salts used at virus propagation stages and the first two peaks were collected and purified 
using an ion exchange chromatography column, with specific fractions (7 to 11) driven to the final step, a new 
desalting process. For the anion exchange column, start (20 mM Tris-HC, pH 8.0) and elution buffers (20 mM 
Tris-HC, 1 M NaCl, pH 8.0) were used, whereas in desalting steps a phosphate buffer (20 mM sodium phosphate, 
0.15 M NaCl, pH 7.0) was prepared. Flow rate of 5 mL.min−1 was adopted for both columns. Finally, viral titer was 
measured at 37 °C by double-agar overlay method30 using E. coli 30 as the plating host. Phage stocks were stored 
at 4 °C for further analysis.
Bioinformatic analysis. Phage genome extraction, sequencing and annotation methodologies are described 
according to Duarte et al.31. Hypothetical proteins were manually checked for homologs using UNIPROT 
database. Protein isoelectric point and molecular weight were obtained using ExPASy32. Putative tRNAs and 
Rho-independent transcription terminators were, respectively, predicted using tRNAscan-SE33 and ARNnold 
web tool34. The Database of Gene Regulation in Bacteriophages (phiSITE)35 was used in order to check the three 
major classes of promoters (early, middle and late) as well as to confirm putative Rho-independent terminators. 
The CGView Server was used to generate a UFV13 genome graphical map36.
Nucleotide differences between UFV13 and Enterobacteria phage T4 (accession number AF158101.6) 
genomes were performed by checking reading alignments. High-quality Illumina reads were filtered and adaptor 
sequences were removed using Trimmomatic software (ver 0.33)37 (parameters: LEADING:10 TRAILING:10 
SLIDINGWINDOW:4:15 MINLEN:65) and aligned to Enterobacteria phage T4 using Bowtie2 software 
(v2.2.4)38. SAMtools39 was used to convert the output SAM format to BAM format and, subsequently, to sort 
the BAM file. The sorted BAM file was processed with mpileup tool (SAMtools package) in order to extract the 
variants. The Binary Call Format (BCF) created was converted to VCF format using BCFtools39. VCF file and 
Enterobacteria phage T4 genes were used as input for SnpEff program40. Only variants with predicted “high” or 
“moderate” impact on the protein-coding gene were analyzed.
Whole-genomes that represent each genus from the subfamily Tevenvirinae (T4virus, Cc31virus, S16virus, 
Js98virus and Sp18virus) deposited on the International Committee on Taxonomy of Viruses (ICTV) were 
downloaded from NCBI (accession numbers are provided in Supplementary Table 4) and aligned with UFV13 
genome using Progressive MAUVE41. Whole-genome single nucleotide polymorphisms (SNPs) were extracted 
as described in Treu et al.42 and a SNP-based phylogenetic tree was constructed using PHYLIP package43 and 
visualized by dendroscope44. Furthermore, a whole-genome phylogenetic tree was formulated aligning previously 
cited genomes from the Tevenvirinae subfamily. Online tools ClustalW245 and MAFTTT version 746 were used 
for multiple alignment. A neighbor-joining tree was drafted with MEGA747 and visualized with FigTree (http://
tree.bio.ed.ac.uk/software/figtree/).
In silico bacterial hosts of UFV13 were predicted using HostPhinder48.
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vB_EcoM-UFV13 structural protein analysis. With the aim of obtaining the UFV13 structural protein 
profile, proteomic analysis was conducted.
Viral propagation/purification (see item 2.2) were conducted and phage particles concentrated by adding 
NaCl 1 M and polyethylene glycol 8000 (PEG8000) 10% (w/v). The mixture was kept overnight at 4 °C. After a 
centrifugation (10,000 × g, 15 min), viral pellet was resuspended in 1 mL of SM buffer and one volume of chloro-
form followed by centrifugation at 4,000 g for 10 min. An equal volume of trichloroacetic acid (TCA) 10% (v/v) 
was added to the supernatant and incubated on ice for 30 min. The precipitated viral proteins were collected by 
centrifugation (11,000 × g, 20 min), washed three times with acetone (11,000 × g, 10 min) and resuspended in 
water. The BCA Protein Assay Kit (Boster Biological Technology, Wuhan, China) was used to estimate protein 
concentrations.
For protein profiling, the viral proteins were separated via sodium dodecyl sulfate-polyacrilamide electro-
phoresis (SDS-PAGE) on a15% gel49. Protein bands were highlighted by Coomassie Brilliant Blue R-250 dye 
and removed as described by Shevchenko et al.50. Mass spectrum (MS) was acquired by matrix-assisted laser 
desorption-ionization time of flight (MALDI/TOF-TOF) (Ultraflex III - BRUKER DALTONICS). Spectra inter-
vals between 500 and 3,500 kDa were selected and forwarded for MS/MS analysis. Results were obtained by 
Mascot™ (Matriz Science) software using the NCBl nr protein database. Only proteins and peptides indicated as 
significant by Mascot were considered for further analysis.
Physiological features. Physiological features were assessed in triplicate following the protocols described 
by Jurczak-Kurek et al.51. In each of the following cases, following treatment the phage preparation was diluted 
and tittered as described above (2.2).
pH stability. Viral capability at different acidic and alkaline pH values was evaluated. One mL of purified viruses 
were transferred to 9 mL LB medium with pH 2, pH 4, pH 7 (control), pH 10 and pH 12 at a 1:9 ratio and incu-
bated for 1 h at 37 °C, being proceeded by a 10-fold serial dilution and plating as described in item 2.2. After over-
night incubation at 37 °C, virus stability was determined by the percentage of viruses able to produce lysis plate.
Thermal stability. Thermal stability studies on LB-diluted phage suspensions were made at −20 °C, 40 °C, 62 °C 
and 95 °C, respectively, for 12 h, 40 min, 40 min and 5 min. After these periods, a serial 10-fold dilution was con-
ducted and a specific aliquot was plated and incubated overnight at 37 °C. Viruses that did not undergo any ther-
mal treatment were used as a control.
Viral ability to propagate in different temperatures. Viral replication at different temperatures (4 °C, 22 °C, 30 °C 
and 37 °C) was assessed by spot-assay after 24 hours of incubation using a 10-fold serially diluted viral stock in 
LB medium.
Osmotic shock effect. In order to verify the effect of the osmotic shock on virus particles, a stock aliquot was 
transferred to TM buffer (10 mM Tris–HCl, 10 mM MgSO4; pH 7.2) with sodium chloride 4.5 M, incubated at 
room temperature for 15 min and quickly diluted in TM buffer without sodium chloride. Bacterial viruses incu-
bated in TM buffer without sodium chloride were used as a control.
Antiviral resistance. Antiviral activity of sodium dodecyl sulfate (SDS), sodium lauroyl sarcosinate (Sarkosyl) 
and cetyltrimethylammonium bromide (CTAB) on virus particles was determined incubating a standardized 
viral suspension with 0.09% SDS (20 min at 45 °C), 0.1% CTB (1 min at 22 °C) and 0.1% Sarkosyl (10 min at 22 °C). 
Controls were done considering the same conditions for each antiviral compound but they were substituted for 
TM buffer.
Organic solvent effect. To study the effect of four different organic solvents, a viral suspension was added to 63% 
ethanol, 90% acetone, 90% chloroform and 50% dimethyl sulfoxide (DMSO). Mixtures were incubated for 1 h 
at 22 °C (ethanol and acetone), 1.5 h at 4 °C (chloroform) and 10 min at 4 °C (DMSO). In the next step, 10-fold 
dilutions in TM buffer (10 mM Tris–HCl, 10 mM MgSO4; pH 7.2) were prepared and used for plating. Phages 
incubated in TM buffer under conditions described above, were used as a control.
Animal model and immune response. Escherichia coli 30 strain. The mammary-pathogenic E. coli 
30 was isolated from a dairy cow with acute mastitis and kindly provided by Brazilian Agricultural Research 
Corporation (Empresa Brasileira de Pesquisa Agropecuária – EMBRAPA) Dairy Cattle (Juiz de Fora, Minas 
Gerais, Brazil). E. coli 30 was evaluated for its ability to form biofilm as well as for motility capacity. Motility assays 
were conducted according to Deziel et al.52. Briefly, an overnight E. coli 30 aliquot was washed, suspended in 
distilled and sterilized water, and inoculated in King B medium (peptone 20 g/L, MgSO4.7H2O 1.5 g/L, K2HPO4 
1.5 g/L), supplemented with 1.5, 0.5 and 0.3% of agar for twitching, swarming and swimming tests, respectively. 
Biofilm assay followed the common crystal violet (CV) staining method53. After incubation (37 °C for 48 h), 
wells were washed 3 times with PBS buffer to remove not adherent cells. CV was added at a minimum volume 
capable overcome bacterial suspension volume, making possible quantify all bacterial biomass, and incubated for 
30 minutes at room temperature. To biomass quantify, CV was removed, wells washed with PBS, added ethanol 
to solubilize biomass internal CV crystals, and optical density measured at 560 nm. All assays were performed in 
triplicate.
Antimicrobial susceptibility test of E. coli 30 was assessed by disc diffusion assay using polisensidiscs for 
25 different antibiotics (DME, Araçatuba, São Paulo, Brazil) following the manufacture’s recommendation. The 
results were interpreted according to the standards of the Clinical and Laboratory Standards Institute (CLSI)54.
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E. coli-induced mastitis in mouse. With the aim to evaluate UFV13 effectiveness and the immune response 
against E. coli 30 in vivo, an experimental E. coli-induced mastitis mouse model was used. The trial followed the 
methodology described by Chandler55, with some modifications, and was approved by the Ethics Committee 
(Comissão de ética no uso de animais/UFV) according to the protocol 64/2016. Lactating Balb/c female mice 
(5 to 15 days) was intraperitoneally anesthetized with 10% Ketamine and 2% Xylazine, with subsequent surgical 
operation of the mammary gland by cutting the teat canal of the last two abdominal ceilings (R5 and L5 of each 
animal were used) (Supplementary Figure 4). E. coli 30 (100 UFC/ml), PBS and phage served as the control 
groups, while phage plus bacteria was considered the treatment group (MOI 10). Viral addition was done four 
hours after bacterial inoculation. Three animals were used to perform each experimental group.
In order to assess the lytic activity of the phage vB_EcoM-UFV13 in mammary glands, animals were eutha-
nized 48 hours after the treatment by anesthetic overdose. Infected mammary glands were removed and trans-
ferred to 1.5 ml of (PBS), macerated and serially diluted (1:10) in PBS buffer. A microdrop assay56 was performed 
to estimate E. coli 30 colony-forming unit (CFU).
Cytokines IL-6, TNF-α, IL-2, IFN-γ, IL-4, IL-10 and IL-17A obtained from macerated mammary gland (L5 
and R5 from each animal was pooled) were simultaneously quantified by the Cytometric Bead Array kit (CBA, 
BD Bioscience) in a BD FACSVerse Flow cytometry following manufacturer’s recommendations.
Histological analysis. For histology, mice were euthanized 48 hours after phage treatment. The mammary 
glands were removed and fixed in Karnovsky fixative (paraformaldehyde 4% and glutaraldehyde 4%, pH 7.3). 
Further, the tissues were embedded in paraffin and a 5 µm section was obtained by microtomy, stained with hema-
toxylin and eosin (H & E) and observed under light microscopy. The images were acquired under an Olympus 
DP73 microscope.
Statistical analysis. Statistical analysis was performed with GraphPad Instat 3 software (GraphPad, La Jolla, 
CA, USA) using the one-way analysis of variance (ANOVA) at 95% accuracy level to evaluate the differences 
between mammary gland cytokine production under different conditions. This assay was set up in triplicate and, 
for each animal, the two abdominal ceilings were pooled into one sample. Tukey’s test was used as post hoc test.
Results and Discussion
vB_EcoM-UFV13 genome analysis. Bacteriophage UFV13 was isolated from samples obtained in the 
sewage system of Viçosa, Minas Gerais, Brazil, a well-known source of novel viruses57.
From the genome sequence (165,772 bp, GC content 34.8%), 269 ORFs were predicted and annotated. The size 
is similar to that of other members of the T4virus genus58. In addition, a total of ten tRNA encoding genes (Gln, 
Leu, Gly, Pro, Ser, Thr, Met, Tyr, Asn and Arg) were identified and are organized in a gene cluster without introns 
or pseudogenes (Fig. 1). 13 ORFs showed an identity below 70% with the reference phage T4, while 24 ORFs 
were annotated as hypothetical protein coding sequences. ORFs 50 and 232 are, respectively, coding sequences 
for T2 and T6 bacteriophage proteins. 13 ORFs encode for Shigella phage proteins (pSs-1, Shfl2, Shf125875, SH7, 
SHBML-50-1). Genes for IpII and IpX were not identified in the UFV13 phage genome. Gene and protein infor-
mation such as genomic coordinates, protein weight, pI and putative function for each UFV13 ORF are reported 
in Supplementary Table 1.
Functional categorization of UFV13 genes (Supplementary Table 2) revealed that nonessential and auxiliary 
genes mainly related to homing endonucleases of introns such as I-TevI, I-TevII and I-TevIII are absent, as with 
some of their related introns like mob and seg genes (Table 1). Homing endonucleases of introns are considered 
systems associated with gene conversion events, transference of mobile elements and gene exclusion in mixed 
infections14. In fact, genome analysis suggests a recent mixed infection among UFV13 and Shigella phage Shfl2, 
once segF was substituted by soc.1 and soc.2 from Shigella phage Shfl2. According to Belle et al.58, segF was absent 
in T2 phages, but the region is occupied by soc.1 and soc.2.
Similarity analysis using the deposited genomes from Yersinia phage PST and Shigella phage Shfl2 showed 
that the bacteriophage UFV13 has 97% identity with both phages. However, it has a larger percentage of aligned 
genome (96%) for the Shfl2, and 90% of genome aligned to phage PST (Supplementary Figure 1). Comeau et al.59, 
characterized Yersinia phage PST genome, containing dsDNA with 167,785 bp, 35.3% GC content and 9 tRNAs, 
whose values are near to those found for the phage UFV13, with 34.8% GC content. Jun et al., (2016) identified 
10 tRNAs for both pSs-1 and Shfl2 viruses infecting Shigella spp. as host. Despite little existing knowledge about 
tRNAs functioning in phage life cycles, high tRNAs numbers found in some bacteriophages could be propor-
tional to phage genomes sizes and are related to a short latent period and high burst size value60.
In the total, 35, 21 and 31, early, middle and late promoter regions respectively, were predicted, which corre-
sponds to 73% of the promoters identified for the T4 genome (Supplementary Table 3). As expected, no promoter 
regions for mob and seg genes were found, along with I-TevII and internal protein II (ipII).
Overall, termination of transcription in T4 bacteriophages occurs by an intrinsic termination signal, a 
stem-loop arrangement accompanied by a U-rich region, or a Rho-dependent termination mechanism61. For 
UFV13, 82 Rho-independent transcription terminators were predicted and compared against phiSITE database. 
30 sequences displayed high identity with the reference phage, while five were not predicted but were found using 
the sequences available on the phiSITE. Terminators for the genes 45, 5.4/6′, 34/35, 35, 37, nrdA, uvsY.−2 and 
56/segF were not found or even identified using phiSITE (Table 2), while for the genes such as regA, wac, 24(b) 
and 30.9(b) were, respectively, detected on the ORFs 52, 163, 178 and 208. According to Miller et al. (2003), gen-
erally 34 terminators are found in the T4 genome. The absence of terminators for the genes nrdA and 56/segF can 
be explained by their absence, since these genes were not annotated. The significance of terminators within genes 
is unknown but have been described for T4 phages14.
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A total of 5,071 filtered variants (4,975 SNPs, 86 insertions and 10 deletions) were identified (1 variant every 33 
bases) between UFV13 and T4. 83,656 effects were assigned and categorized (395 high (0.472%), 1,670 low (1.996%), 
2,722 moderate (3.25%) and 78,869 modifier (94.28%). The number of effects by functional class is: missense 2,879 
(60.79%), nonsense 187 (3.95%) and silent 1,670 (35.26%). Considering only genes with high or moderate variants, 
the mainly affected protein category was that related to virion structural proteins, with gp7 being the most affected 
(Fig. 2). This protein is considered the second largest protein in the baseplate and is one of the seven components 
associated with wedge assembly and stability62. The large number of SNPs found in virion proteins reflects the diver-
sification of phage UFV13 from the classical T4 and can be associated with the high capability to infect different 
bacterial genus such as Escherichia, Morganella and Shigella, an uncommon phage feature (data not shown).
In order to evaluate the phylogenetic relationship between UFV13 and genera belonging to the subfamily 
Tevenvirinae (T4virus, Cc31virus, S16virus, Js98virus and Sp18virus), a whole-genome tree was constructed. The 
phylogenetic tree divided phages into four clusters with vB_EcoM-UFV13 possessing the closest relationship 
with Shigella Shfl2 and Yersinia phage PST (Fig. 3), a result also supported by the SNP-based phylogenetic tree 
(Supplementary Figure 2).
With the aim to establish the host range of phage UFV13 host range, in silico Host Phinder test was conducted. 
Four bacterial genera were predicted to be infected by UFV13: Escherichia (E-value: 5.9e−1), Yersinia (E-value: 
5.8e−1), Shigella (E-value: 6.3e−1) and Salmonella (E-value: 1.1e−2).
Viral protein analysis. SDS PAGE analysis revealed the presence of eight proteins (Supplementary Figure 3). 
Among these, four proteins were chosen and analyzed by MALDI/TOF-TOF, with the following being identified: 
UFV13_gp243 long tail fiber proximal subunit (139.95 kDa), E. coli chaperonin GroL (57.36 kDa), Escherichia 
Figure 1. Genome map of vB_EcoM-UFV13. The linear genome was circularized in order to improve its 
visualization. CDS, ORF, GC content, GC skew+ and GC skew- are reported in circles from outside inwards.
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phage vB_EcoM_112 major capsid protein (56.09 KDa) and E. coli outer membrane protein C (36.77 kDa). These 
proteins are deposited at UNIPROT under accession numbers A0A160CBJ3, A0A017I9Q1, A0A160CBB0 and 
A0A148HSV3, correspondingly. The presence of a common viral receptor (OmpC) and the chaperonin GroL 
highlights the need for viral purification enhancement. Viral isoelectric points are usually below six and some of 
them are able to bind to anion and cation exchange matrixes. However, host cell DNA is efficiently removed by 
cation exchanger columns, while host cell proteins are effectively eliminated by anion exchange63.
Physiological features. Viral ability to survive in a wide range of adverse conditions is a desired character-
istic for therapeutic as well as a biological control agents64. Thus, phage stability was evaluated in different physical 
and chemical conditions.
UFV13 was relatively stable within a pH range of 7.0–12.0. An approximate 1 log-fold reduction on viral titer 
was observed after incubation at pH 4.0 (18% of survivability) (Fig. 4A). Interestingly, phage UFV13 was inacti-
vated after 1 h of incubation at pH 2.0, but not at pH 12 (68% viral viability), which is indicative of considerable 
virion stability at basic pH values.
UFV13 was able to lyse E. coli at 30 °C and 22 °C with a plating efficiency of 69 and 56%, respectively (Fig. 4B). 
No lysis plates were observed after storage at 4 °C, which may be indicative of DNA injection without host lysis.
Viral thermal inactivation occurred in the extreme tested temperatures 95 and −20 °C (0 and 24% survival, 
respectively), while viral titer dropped to 50% when UFV13 was incubated for 40 min at 62 °C (Fig. 4C). No sig-
nificant reduction of phage titer was observed after thermal treatment at 40 °C.
It was found that osmotic pressure change, detergent and organic solvents determined a significant titer drop 
of UFV13. A survivability of 12% was observed when UFV13 underwent a rapid dilution from high-concentration 
NaCl buffer to low-concentration ones (Fig. 4D). The anionic detergent Sarkosyl reduced the number of viable 
viral particles by 74%, while CTAB and SDS resulted in a complete inactivation of this virus (Fig. 5). Anti-phage 
activity was also evidenced after exposure to ethanol, chloroform, acetone and DMSO.
Physiological features evaluated in this study are in accordance with Jurczak-Kurek et al. (2016). In a broad 
physiological study using 83 bacteriophages isolated from urban sewage, the same source of UFV13, it was ver-
ified that the vast majority of phages were sensitive to a temperature of 62 °C (survival below 70%), were able to 
survive in basic pH (ranging from 10 to 12), were susceptible to detergents and organic solvents, except chloro-
form, and were also resistant to osmotic shock.
Viral stability assays have also been shown that UFV13 can survive in raw milk and it has potential capability 
to survive in mastitic milk. In general, mastitis can dampen the quality of raw milk composition, which includes 
increased levels of Na+/Cl− and pH65. Evaluating a bacteriophage cocktail composed of two T4 phages in raw milk 
against E. coli, Porter et al. (2016) observed a 3.3- to 5.6-log reduction of bacterial growth over a 12-h physiologic 
temperature. As discussed below (item 3.4), this study showed UFV13 activity against E. coli in lactating female mice.
E. coli-induced mastitis mouse model. E. coli 30, an isolate obtained from a dairy cow with acute mas-
titis, displays resistance to 14 of 25 evaluated antibiotics (Supplementary Table 5). This bacterium is resistant to 
at least three different antimicrobial drug classes, which allows its classification as a multi-drug resistant strain66 
Gene Function Relevance
mobA Pseudogene of Mob site-specific DNA endonuclease Nonessential
mobB Putative site-specific intron-like DNA endonuclease Nonessential
mobC Putative intron-like DNA endonuclease Auxiliary
mobD Putative site-specific DNA endonuclease Nonessential
mobE Putative mobile endonuclease Nonessential
segA Site-specific intron-like DNA endonuclease Nonessential
segB Probable site-specific intron-like DNA endonuclease Nonessential
segC Site-specific intron-like DNA endonuclease Nonessential
segD Probable site-specific intron-like DNA endonuclease Nonessential
segE Probable site-specific intron-like DNA endonuclease Nonessential
segF Intron-like endonuclease. A probable fusion protein, generated from 56 and 69 by hopping of ribosomes across a pseudoknot, is larger Nonessential
repEA Protein auxiliary for initiation from oriE Auxiliary
repEB Protein required for initiation from oriE Auxiliary
I-TevI Intron-homing endonuclease Nonessential
I-TevII Endonuclease for nrdD-intron homing Nonessential
I-TevIII Defective intron homing endonuclease Nonessential
rnaD Stable RNA Auxiliary
stp Peptide modulating host restriction system Auxiliary
nrdA Ribonucleotide reductase α subunit Auxiliary; nrd-defective hosts
Table-1. Genes not predicted in vB_EcoM-UFV13 based on the reference genome Enterobacteria phage T4 
(accession number NC_000866). Function and relevance were integrally withdrawn from Miller et al. (2003).
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Moreover, of the four types of virulence factors analyzed (biofilm forming capability and motility types: swarm-
ing, swimming and twitching) the E. coli 30 was positive for biofilm formation, swarming, and swimming, being 
negative only for the twitching (Supplementary Table 6). Studies correlated this virulence factors to an increase in 
pathogenicity and immune response evasion67,68.
Intergenic location Genome position Strand Predicted Rho-independent transcription terminator site
Free energy
(kcal/mol)
39.1 4310..4341 Minus TTTAAATAAAAGGCCTTCGGGCCTTTAGCTTTATG −10.60
soc 15135..15168 Minus AATTCAAGGACTCCTTCGGGAGTCCTTTTTCATT −16.30
uvsX-40 21337..21371 * * *
Unknown gene 25445..25477 Minus TAAATCTAGGGACCTCCGGGTCCCTTTTTCACAC −12.10
regA 28228..28259 * * *
α-gt 35109..35140 Minus ACAAAATAAAGGGCTTCGGCCCTTTAGCTTTATA −10.60
α-gt.2 36378..36411 Minus TATGCGGATAGGAGCTTCGGCTCCTATATTGCTT −14.20
55.3 38744..38775 Minus GTTTAGCTAAGGGCTTCGGCCCTTTTTGGATAAT −10.60
nrdH 39707..39739 Minus GATTAAGACGGGCCCTCTGGGCCTTTCTTTCTCG −8.80
Pin 43124..43166 Minus AAATACCCTTATCTATTTAAGGTAAGGGTTTATTA −10.70
nrdC.11 51781..51818 Minus AATGATAGGGAGCCTTCGGGCTCCCTTTTTTATT −18.40
rI.−1 55358..55389 Minus TAACATTAGTCTCCTTCGGGAGACTTTTTTCATT −13.50
Vs 58098..58128 Minus TATATCAAGGGCGATATTGTCGCCCTTTTTCTTTA −11.40
e.6 66465..66498 Minus ATAATGATAAGGGGCTTCGGCCCCTATTACTTGG −13.90
RNA C 69462..69503 Minus GCTTAGCCCCAGCCGAAAGGTTGGGGCTTTTTA −17.40
8 84691..84728 Plus TAAATTAAGGGAGCCCATGGGCTCCCTTTTTCTT −16.50
wac 91126..91161 * * *
19 98662..98695 Minus AAGCAGGATGGGGATTTCTCCCCATTCaTTTTAT −14.50
23 151432..151461 Plus AATTGAGGGAGCCTTCGGGTTCCCTTTTTCTTTA −16.70
24(a) 105412..105447 Plus AAAACAAAGGGACCTTTCGGTCCCTTTTTATTTA −12.30
24(b) 105467..105499 * * *
hoc 106999..107032 Minus TAATCATAAGGGGCTTCGGCCCCTTTCTTCATTT −14.50
54 118931..118972 Plus CTAACAATGGGGACCGAAAGGTCCCCATATTTTT −19.90
alt.1 123501..123532 Minus GATTACTAAAGGCCTTCGGGCCTTTAaTTTTATAA −14.80
30.9(a) 128117..128154 Minus AAGTTGAGGACTCCTTCGGGAGTCCTTTTTTATT −16.30
30.9(b) 128162..128198 * * *
nrdB 135904..135939 Minus TTAAGGAGTGGGCCGCAAGGCCCATTTTATTATG −15.30
32 143116..143152 Minus ATTAATTGGGGACCTCTAGGGTCCCCTTTTTTAT −14.90
T 157574..157618 Plus CAAACCCTCGTTGAATTCGTCGATGAGGGTTTTC −11.10
motA.1 160357..160396 Minus ATTTTAGGGAGAGCTTCGGCTCTCCCTTTTTTAT −19.60
Ac 161968..162004 Minus TGCCCTTGCTACTTTATTGGTAGCAcTATATTATG −8.60
denB.1 164573..164601 Minus CAAATAAATAAGGGCTTCGGCCCTTTTGTTTTAA −10.60
5.4 78461..78499 Minus GTCACTCCGCCATGTGTTTCATATGGCTTTTTAA −10.20
Stp 162165..162200 Plus TTCCTCACTGGCGTCCGAAGACGCCTTTAATTTT −10.30
rIIB 164798..164834 Plus TCCTTAGTTAAGGGCCGAAGCCCTTATTTAAATT −10.00
Table-2. Main features of the predicted Rho-independent transcription terminators. The asterisk means that 
absence of terminator prediction by using Arnold or phiSITE programs.
Figure 2. Variants calling between vB_EcoM-UFV13 and Enterobacteria phage T4 were predicted using 
SnpEff. Only variants with predicted “high” or “moderate” impact on the protein-coding gene were analyzed 
and functionally categorized.
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Figure 3. Phylogenetic relationship between phage UFV13 and genera belonging to the subfamily Tevenvirinae 
(T4virus, Cc31virus, S16virus, Js98virus and Sp18virus). vB_EcoM-UFV13 is most closely related to Shigella 
phage Shfl2 and Yersinia phage PST, and is clearly a member of the T4virus genus.
Figure 4. The stability of vB_EcoM-UFV13 under different conditions was evaluated. (A) Reductions of 100, 
82, 4 and 32% of viable particles were observed after incubations, respectively, at pHs 2, 4, 10 and 12. (B) vB_
EcoM-UFV13 was able to replicate at 30 and 22 °C with an efficiency of plating of 69 and 56%, corresponding; 
(C) vB_EcoM-UFV13 was inactivated at 95 °C for 5 min; (D) Osmotic shock changing reduced in 84% viral 
viability.
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Nowadays, several studies have been used mouse mastitis models with the aim to evaluate potential anti-mastitis 
agents for use in dairy cows20–25,69–71 although the authors are aware that cow factors are relevant in the mastitis 
establishment28.
In order to evaluate UFV13′s in vivo activity against an MPEC strain and immune response to this treatment, 
an E. coli-induced mastitis model was employed. A 10-fold reduction of bacterial load was observed after viral 
inoculation using MOI 10 (Supplementary Figure 5).
Seven different cytokines (IL-6, TNF-α, IL-2, IFN-γ, IL-4, IL-10 and IL-17A) were measured, however only 
IL-10, TNF-α and IL-6 were identified as statistically significant (p < 0.05) (Fig. 6).
Studying whether T4 bacteriophage and T4-generated E. coli lysate influence cultures of peripheral blood 
mononuclear cells (PBMCs) activated or not by lipopolysaccharide (LPS), Bocian et al. (2016) observed that 
both preparations considerably increased the percentage of CD14+CD16−CD40+ and CD14+CD16−
CD80 + monocytes in LPS-unactivated PBMCs cultures, as well as the concentration of IL-6 and IL-12. 
Notwithstanding, this result suggests that T4 bacteriophages may act both as a pro-inflammatory inducer, and 
Figure 5. Viral stability under anionic and cationic detergents showed that vB_EcoM-UFV13 was sensible in 
all conditions.
Figure 6. Five different cytokines (IL-6, TNF-α, IL-2, IFN-γ and IL-10) were locally measured. Only IL-10, 
TNF-α and IL-6 were statistically significant (*p < 0.05; **p < 0.01) and is indicative of a pro-inflammatory 
pattern after phage treatment. IL-17A and IL-4 levels were not detected by the Cytometric Bead Array kit.
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also as CD40 activator, for this reason the increased expression of IL-6, IL-10, and TNF-α as a consequence of the 
presence of contaminating LPS left after the purification step rather than a property of the virion.
In an In vivo assessment of cytokine patterns followed by a single-dose T4 bacteriophage application in an E. 
coli induced mastitis mouse model, our work indicates that IL-10 levels decreased locally in phage therapeutic 
group when compared to the negative control (PBS buffer) (Fig. 6A). IL-10 has been extensively studied due its 
immunosuppressive features associated with the downregulation of pro-inflammatory cytokines, such as TNF-α 
and IFN-γ, and the resolution of the inflammatory process72,73. Evaluation of cytokine expression in the mam-
mary gland in a mouse model of Streptococcus agalactiae mastitis performed by Trigo et al. (2009) revealed that 
the maximum concentration of IL-10 occurred after 72 hours and was correlated with a decreased level of TNF-α. 
This finding is in accordance with our results. Reduced IL-10 levels (Fig. 6A) and increased TNF- α (Fig. 6B) and 
IL-6 (Fig. 6D) is indicative of an ongoing inflammatory process. In fact, when only E. coli 30 was inoculated, an 
increased abundance of TNF-α was also observed when compared with the negative control. Although phage 
and E. coli 30 were individually able to induce an inflammatory response, phage treatment (103 PFU) did not 
provoke an additive effect on the production of any pro-inflammatory cytokine. Indeed, the IL-6 level diminished 
(Fig. 6D) after phage treatment. Different to what was found by Trigo et al. (2009), IFN-γ levels were detected in 
all groups, however no statistical difference was observed between the groups, which was also applicable to IL-2 
(Fig. 6C–E, respectively).
The absence of detectable IL-4 and IL-17A cytokines, respectively present in Th2 and Th17 inflamma-
tory responses, indicates that the use of T4 phage in mammary glands infected with E. coli induces Th1 T-cell 
responses. Th1 pattern is involved in a cellular immune response that protects against intracellular infections by 
viruses and microorganisms that grow in macrophages74.
Histological analysis of the mammary gland in the control group (Fig. 7A) shows intact tissue morphology 
described by well delimited cells and acini, as well as the presence of fatty cells and a milky secretion, even when 
E. coli 30 (~100 cells) were inoculated (Fig. 7B). Inoculation of the phage UFV13 (MOI 10) in the treated group 
led to an inflammatory reaction characterized by tissue damage, neutrophil infiltrates and mischaracterization 
of the acini border, although low levels of pro-inflammatory cytokines have been found as discussed previously 
(Fig. 7C).
Conclusion
Viral genomic analysis is a crucial step in bacteriophage screening for their use as an antibacterial agent. The 
UFV13 virus has no lysogenic modules or genes conferring antibiotic resistance. Viral stability analysis in the 
presence of detergents and organic solvents and incubation at different pHs and temperatures, have shown that 
the UFV13 virus presents high survivability at basic pHs and is relatively resistant under incubation at 62 °C for 
40 min. vB_EcoM-UFV13 used in an animal model for mastitis reduced the total bacterial load by 90%, as well 
as inducing pro-inflammatory cytokines such as IL-6 and TNF-α, which makes it a potential biological agent 
capable of controlling acute infections caused by E. coli dairy cows.
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